Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 43.7

(-3.02%)

Total Liabilities Summary of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest annual total liabilities in 2023 was 805.75 Million CNY , up 45.22% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest quarterly total liabilities in 2024 Q3 was 945.04 Million CNY , up 15.89% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported annual total liabilities of 554.86 Million CNY in 2022, up 17.3% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported annual total liabilities of 473 Million CNY in 2021, up 146.44% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported quarterly total liabilities of 979.51 Million CNY for 2024 Q1, up 21.56% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported quarterly total liabilities of 818.67 Million CNY for 2024 Q2, down -16.42% from previous quarter.

Annual Total Liabilities Chart of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Historical Annual Total Liabilities of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 805.75 Million CNY 45.22%
2022 554.86 Million CNY 17.3%
2021 473 Million CNY 146.44%
2020 191.93 Million CNY 15.1%
2019 166.75 Million CNY 30.61%
2018 127.67 Million CNY 66.2%
2017 76.82 Million CNY 0.0%

Peer Total Liabilities Comparison of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 49.781%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -79.378%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -82.744%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY -17.42%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 63.994%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY -16.184%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 77.92%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -86.921%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 49.766%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 76.927%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY 6.343%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 83.527%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 82.866%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -90.784%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY 21.908%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -84.575%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 91.246%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 47.681%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -169.26%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY -15.744%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 79.367%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -69.307%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 46.004%
Guobang Pharma Ltd. 2.92 Billion CNY 72.447%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -652.672%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 64.096%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 90.374%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 91.672%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 59.165%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 79.154%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 88.809%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 81.792%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 94.764%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 66.193%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -71.393%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 51.17%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY 16.033%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 58.683%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 63.537%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -769.129%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 83.722%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 82.307%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY 20.695%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 71.152%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 92.214%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 57.432%
CanSino Biologics Inc. 3.86 Billion CNY 79.155%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY 9.151%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 49.912%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -124.592%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 45.286%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 76.225%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 93.964%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 94.513%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 77.149%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 91.302%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 92.345%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 98.03%
China National Medicines Corporation Ltd. 14.87 Billion CNY 94.583%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -56.164%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 48.723%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 98.581%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 78.034%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 32.168%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 39.796%